Inside the Johns Hopkins Experiment Teaching Engineers to Fix Global Health’s Toughest Problems

The numbers that open a new study from Johns Hopkins University are stark enough to stop anyone scrolling. Children born in low-income countries are roughly fifteen times more likely to die before their fifth birthday than children born in wealthy nations. Infectious diseases, maternal and neonatal conditions, and injuries account for a huge share of the disease burden in low- and middle-income countries, yet the world’s health research spending has long been distributed in almost the opposite proportion. The Global Forum for Health Research famously described this as the “10/90 gap”: only about ten percent of global health research funding targets the conditions that affect ninety percent of the world’s population. Even though between seventy and one hundred sixty billion dollars are spent on health research and development every year, progress toward real-world impact in the poorest settings remains painfully slow.

A new analysis published in Biomedical Engineering Education argues that part of the solution lies not in new devices alone, but in how engineers are trained to create them. The paper, from researchers at the Johns Hopkins Center for Bioengineering Innovation and Design, known as CBID, examines more than a decade of the center’s global health track and concludes that a specific educational model, one that is integrated, immersive, and relentlessly iterative, can turn graduate students into innovators whose ideas actually reach patients. The study is the first structured translation of CBID’s innovation framework into global health terms, and its results offer a rare quantitative look at what happens when design education is built around the messy realities of low-resource health systems rather than the tidy specifications of wealthy ones.

The problem the program set out to solve is well documented. Traditional biomedical engineering education, particularly in the United States, emphasizes capstone design projects that prepare students for the American medical device industry. Students learn to optimize technical performance and satisfy end-user requirements, but they rarely grapple with the systems-level constraints that determine whether a technology is adopted in a low-income country: delivery systems, workforce capacity, maintenance and spare parts, supply chains, financing, regulation, data systems, trust, and cultural fit. A device that performs brilliantly on a benchtop in Baltimore can fail completely in a rural clinic if nobody can power it, repair it, or afford it. The CBID team argues that this gap between technical excellence and real-world feasibility is a core reason so many healthcare innovations never produce population-level outcomes in low- and middle-income countries.

At the heart of the CBID approach is what the center calls the Spiral-Iterative Innovation model, a framework that extends Barry Boehm’s 1988 spiral model for software development and its later adaptation for medical devices, while borrowing principles from the lean startup movement. The model organizes every issue essential to a healthcare solution’s success into four quadrants: clinical and public health, business and sustainability, technical, and entrepreneurship or execution. The central assumption is radical in its simplicity. An unmet need cannot be fully understood until all four aspects are considered, and complete information for any of them is never available at the start of a project. Instead of finishing technical development before validating clinical and business assumptions, as the traditional bench-to-bedside approach does, teams must advance in all four quadrants simultaneously, at a depth appropriate to the project’s stage, building evidence and reducing risk with each outward turn of the spiral.

This simultaneity is what distinguishes CBID from other leading frameworks. Stanford’s Biodesign program, widely respected in the field, addresses the same four areas but largely in sequence, which can mean that a critical constraint in one domain surfaces only after significant resources have been committed elsewhere. The lean startup method iterates rapidly but lacks specificity to healthcare’s regulatory and multi-stakeholder complexity. In the CBID model, each iteration ends with a stage gate at which students and faculty verify that every quadrant has been addressed, then decide whether to continue, pivot, or kill the project. Because effort in each quadrant is kept to the minimum the stage requires, the cost of changing direction stays low. The authors describe the framework with a memorable phrase: it puts the “due” in due diligence, preventing students from over-investing in the technical work they naturally gravitate toward while neglecting the business and execution questions that will ultimately decide the project’s fate.

The curriculum that carries this model is built on several pillars. Projects cannot even begin without a local partner, such as a university, hospital, or nongovernmental organization in the target country, who provides access to stakeholders and guides the work. Students receive formal lectures on global public health and cross-cultural collaboration, then spend roughly a month doing in-country field immersion, conducting ethnographic interviews and observations organized by their partners. Projects are deliberately longitudinal, often spanning multiple years with structured handoffs between cohorts, and each team is supported by a Global Advisory Committee that functions like a cross-functional thesis committee. Funding is secured project by project, and industry partners that join are required to commit to access-oriented pricing and non-exclusive licensing for low- and middle-income country deployment. The academic year itself unfolds in three phases: needs identification culminating in a landscape analysis and field trip, solution concept selection through structured ideation tools like SCAMPER, MECE maps, and morphological boxes, and finally de-risking through prototyping, validation experiments, and business model development.

To evaluate whether any of this actually works, the researchers compiled a database of every global health project since the track’s founding in 2011 and surveyed program alumni. The results are striking. Of sixty-three global health projects completed to date, twenty-one achieved major translational impact, including field pilots, clinical studies, patents, licensing deals, or market introduction. One hundred seventeen alumni responded to the survey, a thirty-nine percent response rate across all graduating years. Among respondents, seventy-seven percent developed prototypes, more than half collected clinical feedback, nearly a third conducted pilot studies, and none reported that their project failed to progress at all. Five projects spun out startups, three of which have reached commercialization, including the nonprofit telehealth platform Intelehealth and the mosquito surveillance venture behind VectorCam. Seven projects licensed their intellectual property to established companies such as Laerdal Global Health, Bosch, Medtronic, Boston Scientific, and DuPont. One licensed technology, HemoGlobe, a noninvasive anemia screening tool commercialized by Bosch, is now in wide use across India and neighboring countries.

The funding trajectory tells its own story. During the academic year itself, ten of the highest-impact projects secured at least six hundred sixty thousand dollars in external funding. After graduation, eleven projects attracted more than twenty-six and a half million dollars, including a one million dollar grant from the National Cancer Institute for the CryoPop cooling device, eight and a half million dollars for Intelehealth, and five point six million dollars from the Gates Foundation for vector control work. At least fourteen patents have been filed across eleven projects, and twelve projects have documented field pilots or clinical studies, including randomized controlled trials. Thirty-three percent of the highest-impact portfolio remains active in ongoing development or commercialization as of 2025.

Just as important as the project outcomes is what alumni say the training did to them. Respondents reported gains in cross-cultural collaboration, systems thinking, managing conflicting stakeholder incentives, ethnographic research, and frugal design, the art of building effective solutions under severe resource constraints. Field immersion was rated the single most valuable component, with eighty-three percent of alumni calling it high or highest value, even among students for whom global health was only a secondary motivation. While relatively few graduates entered global health careers immediately, twenty-two reported first jobs aligned with global health systems, and several were hired directly by partner organizations, including one alumnus who rose to Director of Impact and Implementation at Laerdal Global Health. The authors interpret this pattern carefully: such programs may not dramatically increase the number of engineers entering global health, but they broaden how all graduates approach engineering practice, instilling what they call foundational innovation literacy that transfers to any multidisciplinary environment.

The study is honest about its limits. Alumni participation was incomplete and may introduce response bias, outcomes were reported at the individual level for team projects, and the analysis is descriptive rather than comparative. Alumni themselves offered pointed suggestions for improvement: narrower project scoping, deeper long-term partner engagement, more structured support after field immersion, and earlier integration of business and regulatory planning. Still, the central finding stands as a challenge to engineering educators everywhere. In a world where the disease burden falls hardest on those with the least access to innovation, the CBID model demonstrates that experiential, partner-driven, iterative training can produce both implementable solutions and engineers equipped to design responsibly within complex, resource-constrained systems. As the World Health Organization’s 2023 call to action urges the global community toward health innovation for all by 2030, this Johns Hopkins experiment suggests that the pipeline of capable innovators may be just as critical as the technologies themselves.

Subject of Research: Experiential education models for training biomedical engineers in global health innovation

Article Title: Teaching Global Health Innovation: An Integrated, Immersive, and Iterative Approach

Article References: García del Barrio Cervera, S., Zhou, S., Parikh, K. S., Rincon Torroella, M., Yazdi, Y., & Acharya, S. (2026). Teaching Global Health Innovation: An Integrated, Immersive, and Iterative Approach. Biomedical Engineering Education. https://doi.org/10.1007/s43683-026-00244-7

Image Credits: AI Generated

DOI: 10.1007/s43683-026-00244-7

Keywords: global health, biomedical engineering education, experiential learning, innovation, human-centered design, low-resource settings, medical devices, Johns Hopkins CBID, spiral innovation model, technology translation, LMICs, alumni survey